home
about us
Health Mall
Telemedicine Platform
offline tumor
vaccine
Investors
contact
CN/EN
home
about us
Health Mall
Telemedicine Platform
offline tumor
vaccine
Investors
contact
CN/EN
Investors
Home
Investors
Investor Home
News & Events
Stock Information
Financial Information
Corporate Information
Investor Resources
SEC Filings
Quarterly Results
SEC Filings
Select the filing type and date range you wish to view from the drop-down menus below.
0001702318
Trailing 12-Months
Calendar Year 2025
Calendar Year 2024
Calendar Year 2023
Calendar Year 2022
Calendar Year 2021
Calendar Year 2020
Calendar Year 2019
Calendar Year 2018
Calendar Year 2017
Form
Description
Date
Format
UPLOAD
SEC-generated letter
17/12/24
F-3/A
Registration statement by foreign private issuers - amendmentOpen document
26/11/24
RW
Registration Withdrawal Request
26/11/24
F-3/A
Registration statement by foreign private issuers - amendmentOpen document
21/11/24
6-K
Report of foreign issuer [Rules 13a-16 and 15d-16]
08/11/24
UPLOAD
SEC-generated letter
30/09/24
20-F
Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Open document
30/07/24
CORRESP
Correspondence
28/06/24
F-6 POS
Post-effective amendments for immediately effective filing
24/06/24
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
02/05/24
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
26/03/24
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
08/03/24
424B5
Prospectus [Rule 424(b)(5)]
07/03/24
F-3
Registration statement by foreign private issuers
23/02/24
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
29/01/24
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
22/01/24
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
03/01/24